JP2015519082A5 - - Google Patents

Download PDF

Info

Publication number
JP2015519082A5
JP2015519082A5 JP2015517390A JP2015517390A JP2015519082A5 JP 2015519082 A5 JP2015519082 A5 JP 2015519082A5 JP 2015517390 A JP2015517390 A JP 2015517390A JP 2015517390 A JP2015517390 A JP 2015517390A JP 2015519082 A5 JP2015519082 A5 JP 2015519082A5
Authority
JP
Japan
Prior art keywords
homologous
region
certain embodiments
sequence
homology
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015517390A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015519082A (ja
JP6279562B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/045382 external-priority patent/WO2013188522A2/en
Publication of JP2015519082A publication Critical patent/JP2015519082A/ja
Publication of JP2015519082A5 publication Critical patent/JP2015519082A5/ja
Application granted granted Critical
Publication of JP6279562B2 publication Critical patent/JP6279562B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015517390A 2012-06-12 2013-06-12 条件付きノックアウト対立遺伝子を生成するための方法および組成物 Expired - Fee Related JP6279562B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261658670P 2012-06-12 2012-06-12
US61/658,670 2012-06-12
PCT/US2013/045382 WO2013188522A2 (en) 2012-06-12 2013-06-12 Methods and compositions for generating conditional knock-out alleles

Publications (3)

Publication Number Publication Date
JP2015519082A JP2015519082A (ja) 2015-07-09
JP2015519082A5 true JP2015519082A5 (enExample) 2017-09-28
JP6279562B2 JP6279562B2 (ja) 2018-02-14

Family

ID=49758880

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517390A Expired - Fee Related JP6279562B2 (ja) 2012-06-12 2013-06-12 条件付きノックアウト対立遺伝子を生成するための方法および組成物

Country Status (11)

Country Link
US (1) US20150128300A1 (enExample)
EP (1) EP2858486A4 (enExample)
JP (1) JP6279562B2 (enExample)
KR (1) KR20150023670A (enExample)
CN (1) CN104540382A (enExample)
BR (1) BR112014031080A2 (enExample)
CA (1) CA2876076A1 (enExample)
HK (1) HK1209276A1 (enExample)
MX (1) MX2014015204A (enExample)
RU (1) RU2014153918A (enExample)
WO (1) WO2013188522A2 (enExample)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
GB201122458D0 (en) 2011-12-30 2012-02-08 Univ Wageningen Modified cascade ribonucleoproteins and uses thereof
DK2847335T3 (en) 2012-04-25 2018-08-13 Regeneron Pharma NUCLEASED MEDIUM TARGETING WITH LARGE TARGET VECTORS
LT3401400T (lt) 2012-05-25 2019-06-10 The Regents Of The University Of California Būdai ir kompozicijos, skirtos rnr molekulės nukreipiamai tikslinės dnr modifikacijai ir rnr molekulės nukreipiamam transkripcijos moduliavimui
DE202013012610U1 (de) 2012-10-23 2017-11-24 Toolgen, Inc. Zusammensetzung zum Spalten einer Ziel-DNA, umfassend eine für die Ziel-DNA spezifische guide-RNA und eine Cas-Protein-codierende Nukleinsäure oder ein Cas-Protein, sowie deren Verwendung
DK3138912T3 (en) 2012-12-06 2019-01-21 Sigma Aldrich Co Llc CRISPR-BASED RE-MODIFICATION AND REGULATION
JP2016507244A (ja) 2013-02-27 2016-03-10 ヘルムホルツ・ツェントルム・ミュンヒェン・ドイチェス・フォルシュンクスツェントルム・フューア・ゲズントハイト・ウント・ウムベルト(ゲーエムベーハー)Helmholtz Zentrum MuenchenDeutsches Forschungszentrum fuer Gesundheit und Umwelt (GmbH) Cas9ヌクレアーゼによる卵母細胞における遺伝子編集
US20140315985A1 (en) 2013-03-14 2014-10-23 Caribou Biosciences, Inc. Compositions and methods of nucleic acid-targeting nucleic acids
PL3456831T3 (pl) 2013-04-16 2021-12-06 Regeneron Pharmaceuticals, Inc. Ukierunkowana modyfikacja genomu szczura
CA2905229C (en) * 2013-06-11 2023-10-10 Clontech Laboratories, Inc. Protein enriched microvesicles and methods of making and using the same
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
EP3988649B1 (en) 2013-09-18 2024-11-27 Kymab Limited Methods, cells and organisms
WO2015066119A1 (en) 2013-10-30 2015-05-07 North Carolina State University Compositions and methods related to a type-ii crispr-cas system in lactobacillus buchneri
KR102523466B1 (ko) 2013-11-07 2023-04-20 에디타스 메디신, 인코포레이티드 지배적인 gRNA를 이용하는 CRISPR-관련 방법 및 조성물
RU2685914C1 (ru) 2013-12-11 2019-04-23 Регенерон Фармасьютикалс, Инк. Способы и композиции для направленной модификации генома
US9840699B2 (en) 2013-12-12 2017-12-12 President And Fellows Of Harvard College Methods for nucleic acid editing
CN103725712B (zh) * 2014-01-17 2016-03-30 上海金卫生物技术有限公司 一种无物种限制的条件性基因敲除用中间载体及其制备方法和用途
US10787654B2 (en) 2014-01-24 2020-09-29 North Carolina State University Methods and compositions for sequence guiding Cas9 targeting
CN106460003A (zh) 2014-04-08 2017-02-22 北卡罗来纳州立大学 用于使用crispr相关基因rna引导阻遏转录的方法和组合物
US20170029805A1 (en) * 2014-04-14 2017-02-02 Maxcyte, Inc. Methods and compositions for modifying genomic dna
WO2015191911A2 (en) * 2014-06-12 2015-12-17 Clontech Laboratories, Inc. Protein enriched microvesicles and methods of making and using the same
US11254933B2 (en) * 2014-07-14 2022-02-22 The Regents Of The University Of California CRISPR/Cas transcriptional modulation
AU2015298571B2 (en) 2014-07-30 2020-09-03 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
CN107429241B (zh) 2014-08-14 2025-10-24 百奥赛图(北京)医药科技股份有限公司 Dna敲入系统
JP6806668B2 (ja) * 2014-08-19 2021-01-06 プレジデント アンド フェローズ オブ ハーバード カレッジ 核酸をプロービングおよびマッピングするためのrna誘導型システム
WO2016033298A1 (en) 2014-08-28 2016-03-03 North Carolina State University Novel cas9 proteins and guiding features for dna targeting and genome editing
CN104293833B (zh) * 2014-10-09 2017-10-10 西北农林科技大学 一种基于TALEN介导的Sp110巨噬细胞特异打靶载体及重组细胞
AU2015330699B2 (en) 2014-10-10 2021-12-02 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
CN104404036B (zh) * 2014-11-03 2017-12-01 赛业(苏州)生物科技有限公司 基于CRISPR/Cas9技术的条件性基因敲除方法
AU2015342749B2 (en) 2014-11-07 2022-01-27 Editas Medicine, Inc. Methods for improving CRISPR/Cas-mediated genome-editing
US11470826B2 (en) 2014-11-17 2022-10-18 National University Corporation Tokyo Medical And Dental University Method of conveniently producing genetically modified non-human mammal with high efficiency
KR102531016B1 (ko) 2014-11-21 2023-05-10 리제너론 파마슈티칼스 인코포레이티드 쌍 형성된 가이드 rna를 사용하는 표적화된 유전자 변형을 위한 방법 및 조성물
JP6885876B2 (ja) 2015-04-13 2021-06-16 マックスサイト インコーポレーティッド ゲノムdnaを改変するための方法および組成物
CN108026536A (zh) 2015-05-29 2018-05-11 北卡罗来纳州立大学 使用crispr核酸筛选细菌、古细菌、藻类和酵母的方法
ES2960226T3 (es) 2015-06-15 2024-03-01 Univ North Carolina State Métodos y composiciones para la administración eficiente de ácidos nucleicos y antimicrobianos basados en ARN
US11279928B2 (en) 2015-06-29 2022-03-22 Massachusetts Institute Of Technology Compositions comprising nucleic acids and methods of using the same
US20180320186A1 (en) * 2015-08-20 2018-11-08 Inter-University Research Institute Corporation Research Organization Of Information And Systems Method for site-specific insertion of foreign dna into a genome in an animal cell and a cell obtained using same
WO2017053879A1 (en) 2015-09-24 2017-03-30 Editas Medicine, Inc. Use of exonucleases to improve crispr/cas-mediated genome editing
EP3356533A1 (en) 2015-09-28 2018-08-08 North Carolina State University Methods and compositions for sequence specific antimicrobials
IL294014B2 (en) 2015-10-23 2024-07-01 Harvard College Nucleobase editors and uses thereof
EP3386550B1 (en) * 2015-12-07 2021-01-20 Arc Bio, LLC Methods for the making and using of guide nucleic acids
US11542466B2 (en) 2015-12-22 2023-01-03 North Carolina State University Methods and compositions for delivery of CRISPR based antimicrobials
CN107022572A (zh) * 2016-02-01 2017-08-08 河北伊维沃生物科技有限公司 Ldl受体基因敲除的基因工程仓鼠
US11845933B2 (en) 2016-02-03 2023-12-19 Massachusetts Institute Of Technology Structure-guided chemical modification of guide RNA and its applications
WO2017147555A1 (en) * 2016-02-26 2017-08-31 Lanzatech New Zealand Limited Crispr/cas systems for c-1 fixing bacteria
US11597924B2 (en) 2016-03-25 2023-03-07 Editas Medicine, Inc. Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
WO2017180694A1 (en) 2016-04-13 2017-10-19 Editas Medicine, Inc. Cas9 fusion molecules gene editing systems, and methods of use thereof
CA3027752A1 (en) * 2016-06-27 2018-01-04 Baylor College Of Medicine Human liver chimeric non-human animal with deficient p450 oxidoreductase and methods of using same
KR102827276B1 (ko) 2016-08-03 2025-07-01 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
CN109804066A (zh) 2016-08-09 2019-05-24 哈佛大学的校长及成员们 可编程cas9-重组酶融合蛋白及其用途
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
CN107779462B (zh) * 2016-08-29 2021-06-04 中国科学院分子细胞科学卓越创新中心 双同源重组谱系示踪技术
KR20240007715A (ko) 2016-10-14 2024-01-16 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
GB201617559D0 (en) 2016-10-17 2016-11-30 University Court Of The University Of Edinburgh The Swine comprising modified cd163 and associated methods
CN109906030B (zh) 2016-11-04 2022-03-18 安健基因公司 用于产生仅重链抗体的经基因修饰的非人动物和方法
EP3546575B1 (en) * 2016-11-28 2024-07-17 Osaka University Genome editing method
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
TW201839136A (zh) 2017-02-06 2018-11-01 瑞士商諾華公司 治療血色素異常症之組合物及方法
WO2018165631A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Cancer vaccine
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
WO2018165629A1 (en) 2017-03-10 2018-09-13 President And Fellows Of Harvard College Cytosine to guanine base editor
KR20240116572A (ko) 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
US11866726B2 (en) * 2017-07-14 2024-01-09 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
WO2019023680A1 (en) 2017-07-28 2019-01-31 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
WO2019139645A2 (en) 2017-08-30 2019-07-18 President And Fellows Of Harvard College High efficiency base editors comprising gam
CN111757937A (zh) 2017-10-16 2020-10-09 布罗德研究所股份有限公司 腺苷碱基编辑器的用途
EP3724214A4 (en) 2017-12-15 2021-09-01 The Broad Institute Inc. SYSTEMS AND METHODS FOR PREDICTING REPAIR RESULTS IN GENETIC ENGINEERING
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
CN108998483B (zh) * 2018-08-17 2021-04-30 武汉核圣生物技术有限公司 利用单亚基RNA聚合酶进行体外转录合成sgRNA的方法
US12264313B2 (en) 2018-10-01 2025-04-01 North Carolina State University Recombinant type I CRISPR-Cas system and uses thereof for genome modification and alteration of expression
US12264330B2 (en) 2018-10-01 2025-04-01 North Carolina State University Recombinant type I CRISPR-Cas system and uses thereof for killing target cells
EP3861120A4 (en) 2018-10-01 2023-08-16 North Carolina State University Recombinant type i crispr-cas system
US12203123B2 (en) 2018-10-01 2025-01-21 North Carolina State University Recombinant type I CRISPR-Cas system and uses thereof for screening for variant cells
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
JP7657726B2 (ja) 2019-03-19 2025-04-07 ザ ブロード インスティテュート,インコーポレーテッド 編集ヌクレオチド配列を編集するための方法および組成物
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
AU2020284016A1 (en) 2019-05-29 2021-12-23 Monsanto Technology Llc Methods and compositions for generating dominant alleles using genome editing
CN113557408A (zh) * 2019-05-29 2021-10-26 孟山都技术公司 用于使用基因组编辑产生显性矮株型等位基因的方法和组合物
CN110512005B (zh) * 2019-06-05 2021-05-14 浙江大学 泛素特异性蛋白酶8在调控湖羊肉质及育种中的应用
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
JP2023525304A (ja) 2020-05-08 2023-06-15 ザ ブロード インスティテュート,インコーポレーテッド 標的二本鎖ヌクレオチド配列の両鎖同時編集のための方法および組成物
ES3035361T3 (en) 2020-10-15 2025-09-02 Hoffmann La Roche Nucleic acid constructs for va rna transcription
CN113678789A (zh) * 2021-08-26 2021-11-23 嘉兴学院 Mir-379/410基因簇敲除的小鼠模型及其构建方法
GB202118058D0 (en) 2021-12-14 2022-01-26 Univ Warwick Methods to increase yields in crops
GB2621813A (en) 2022-06-30 2024-02-28 Univ Newcastle Preventing disease recurrence in Mitochondrial replacement therapy
GB202314578D0 (en) 2023-09-22 2023-11-08 Univ Manchester Methods of producing homoplasmic modified plants or parts thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US713608A (en) 1901-07-06 1902-11-18 William J Condlon Course-indicator for ships.
US5436150A (en) 1992-04-03 1995-07-25 The Johns Hopkins University Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
AU6234594A (en) 1993-02-12 1994-08-29 Johns Hopkins University, The Functional domains in (flavobacterium okeanokoites) (foki) restriction endonuclease
US7135608B1 (en) 1997-08-28 2006-11-14 The Salk Institute For Biological Studies Site-specific recombination in eukaryotes and constructs useful therefor
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
AU2002316095A1 (en) * 2001-05-11 2002-11-25 Genome Therapeutics Corporation Hbm variants that modulate bone mass and lipid levels
US20070218071A1 (en) * 2003-09-15 2007-09-20 Morris David W Novel therapeutic targets in cancer
CN101273141B (zh) * 2005-07-26 2013-03-27 桑格摩生物科学股份有限公司 外源核酸序列的靶向整合和表达
CA2673668A1 (en) * 2006-12-29 2008-07-10 Osprey Pharmaceuticals Usa, Inc. Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof
ATE522611T1 (de) * 2007-06-01 2011-09-15 Omt Inc Zusammensetzungen und verfahren zur hemmung engodener immunglobulingene und zur erzeugung transgener menschlicher idiotypischer antikörper
WO2009054985A1 (en) * 2007-10-25 2009-04-30 Sangamo Biosciences, Inc. Methods and compositions for targeted integration
US20110023143A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of neurodevelopmental genes in animals
EP2456877A1 (en) * 2009-07-24 2012-05-30 Sigma-Aldrich Co. LLC Method for genome editing
US20120192298A1 (en) * 2009-07-24 2012-07-26 Sigma Aldrich Co. Llc Method for genome editing
PT2510096E (pt) 2009-12-10 2015-02-04 Univ Iowa State Res Found Inc Modificação do adn modificada pelo efector tal
US20120204282A1 (en) * 2011-02-04 2012-08-09 Sangamo Biosciences, Inc. Methods and compositions for treating occular disorders
LT3401400T (lt) * 2012-05-25 2019-06-10 The Regents Of The University Of California Būdai ir kompozicijos, skirtos rnr molekulės nukreipiamai tikslinės dnr modifikacijai ir rnr molekulės nukreipiamam transkripcijos moduliavimui

Similar Documents

Publication Publication Date Title
JP2015519082A5 (enExample)
JP2017512767A5 (enExample)
CY1125385T1 (el) Συστημα πολλαπλων φορεων και χρησεις αυτου
Wilkinson et al. Zebrafish as a model of cardiac disease
JP2017002079A5 (enExample)
JP2017501211A5 (enExample)
EP4410976A3 (en) Methods of using zscan4 for rejuvenating human cells
EP3715454A4 (en) COMPLEX FOR GENOME EDITING WITH STABILITY AND FEW SIDE EFFECTS AND NUCLEIC ACID TO ENCODE IT
EA201890274A1 (ru) Векторная система из аденовируса 9 птиц (fadv-9) и связанные способы
JP2017513944A5 (enExample)
JP2020086730A5 (enExample)
任亚丽 The World of Subversion And Renewal-Approaching The Carnivalized Characteristics in Winesburg, Ohio
白妍 Author, Author of Da Vid Lodgf: from The Perspective of Polyphonic Novel
JIANG New Laocoon: On Literature and Art as Event
石闻熙 Tuhao, Let's Make Friends!
Bobrysheva Improving the efficiency of management of the regional health care system
Pogorelaya MANAGEMENT OF INVENTIVE ACTIVITY
尹继成 Lolita As a Metafiction
梁箫箫 Emily Watcher
TR201302590A2 (tr) Diflunisalden hareketle yeni bileşiklerin sentezi.
Ben Khelifa Mutations in DNAH1, which encodes an inner arm heavy chain dynein, lead to male infertility from multiple morphological abnormalities of the sperm flagella: P16
杨正林 Genetic Variants in the ABCA1 gene are Associated with Primary Open-Angle Glaucoma
横井佐織 Genetic studies on the role of vasotocin and isotocin in social motivation of medaka fish
RU2015148624A (ru) Генетическая конструкция рБТШ70 для экспрессии основного человеческого стресс белка, используемого в терапевтических целях, в молоке и линия трансгенных мышей, содержащих данную конструкцию
Shimeng On Aesthetic Politics in the Cinematic Rewriting of Lolita